The role of androgens and anabolic steroids in the treatment of cancer.
D000230:Adenocarcinoma / Q000188:drug therapy; D000380:Agranulocytosis / Q000188:drug therapy; D045930:Anabolic Agents / Q000627:therapeutic use*; D000728:Androgens / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007414:Intestinal Neoplasms / Q000188:drug therapy; D007958:Leukocyte Count; D008080:Liposarcoma / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy; D009277:Nandrolone / Q000627:therapeutic use; D013739:Testosterone / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D045930:Anabolic Agents; D000728:Androgens; D000970:Antineoplastic Agents; D013739:Testosterone; D009277:Nandrolone